Home ETF List About

Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / FundiShares US Medical Devices UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerUMDV.AS(USD) CXE
ETF TickerUMDV(USD) Euronext Amsterdam

Holdings detail for IART

Stock NameIntegra LifeSciences Holdings
TickerIART(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS4579852082
LEIWB7IJCYY8YFTENS4O147

Show aggregate IART holdings

News associated with IART

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives $18.63 Consensus Target Price from Analysts
Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) have received an average recommendation of “Reduce” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating […] - 2025-08-06 02:14:54
Integra LifeSciences (NASDAQ:IART) Shares Up 8.8% on Better-Than-Expected Earnings
Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) traded up 8.8% during trading on Thursday following a better than expected earnings announcement. The company traded as high as $14.07 and last traded at $13.46. 362,656 shares were traded during trading, a decline of 62% from the average session volume of 964,277 shares. […] - 2025-08-01 03:10:52
Victory Capital Management Inc. Acquires 135,308 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Victory Capital Management Inc. raised its holdings in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 1,067.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 147,982 shares of the life sciences company’s stock after buying an additional 135,308 shares during the quarter. […] - 2025-07-28 05:16:52
Bank of New York Mellon Corp Sells 30,447 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Bank of New York Mellon Corp decreased its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 6.5% in the 1st quarter, Holdings Channel.com reports. The fund owned 437,515 shares of the life sciences company’s stock after selling 30,447 shares during the quarter. Bank of New York Mellon Corp’s holdings in Integra LifeSciences […] - 2025-07-22 06:22:52
11,425 Shares in Integra LifeSciences Holdings Corporation (NASDAQ:IART) Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC acquired a new position in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) in the 1st quarter, Holdings Channel reports. The firm acquired 11,425 shares of the life sciences company’s stock, valued at approximately $251,000. Other hedge funds also recently added to or reduced their stakes in the company. Assenagon […] - 2025-07-10 04:14:55
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $18.63 Consensus PT from Analysts
Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been assigned a consensus rating of “Reduce” from the nine brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy […] - 2025-06-17 02:49:03
Analyzing Integra LifeSciences (NASDAQ:IART) and Arch Therapeutics (OTCMKTS:ARTH)
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Volatility and Risk Arch Therapeutics has a […] - 2025-06-16 02:40:44
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Squarepoint Ops LLC
Squarepoint Ops LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 71.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 25,285 shares of the life sciences company’s stock after selling 64,458 shares during the period. Squarepoint Ops LLC’s holdings in Integra LifeSciences were worth $573,000 as […] - 2025-06-04 05:48:48
75,900 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Bought by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 75,900 shares of the life sciences company’s stock, valued at approximately $1,721,000. Other hedge funds and other institutional investors have also recently bought and sold […] - 2025-06-03 05:34:56
BNP Paribas Financial Markets Has $333,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)
BNP Paribas Financial Markets cut its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.9% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,690 shares of the life sciences company’s stock after selling 97,085 shares during the period. BNP Paribas Financial […] - 2025-05-27 06:12:44
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,437 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 38,466 shares of the life sciences company’s stock after buying an additional 1,437 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS […] - 2025-05-27 04:47:03
Financial Review: Integra LifeSciences (NASDAQ:IART) and Vivos (OTCMKTS:RDGL)
Integra LifeSciences (NASDAQ:IART – Get Free Report) and Vivos (OTCMKTS:RDGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares Integra LifeSciences and Vivos’ […] - 2025-05-26 02:20:55
Brokerages Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Price Target at $18.63
Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been given an average recommendation of “Reduce” by the nine analysts that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy […] - 2025-05-23 02:48:54
Integra LifeSciences (NASDAQ:IART) Hits New 12-Month Low Following Weak Earnings
Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings. The company traded as low as $11.60 and last traded at $13.28, with a volume of 7492449 shares trading hands. The stock had previously closed […] - 2025-05-07 03:10:42
Head to Head Review: Integra LifeSciences (NASDAQ:IART) & Venus Concept (NASDAQ:VERO)
Venus Concept (NASDAQ:VERO – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of […] - 2025-05-06 02:46:55
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings
Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) gapped down before the market opened on Monday following a dissappointing earnings announcement. The stock had previously closed at $16.85, but opened at $14.73. Integra LifeSciences shares last traded at $11.88, with a volume of 1,189,112 shares traded. The life sciences company reported $0.41 […] - 2025-05-06 02:10:50
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $22.71 Consensus PT from Analysts
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) has earned an average recommendation of “Reduce” from the nine ratings firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the […] - 2025-04-28 02:24:43
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Sterling Capital Management LLC
Sterling Capital Management LLC boosted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 821.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,166 shares of the life sciences company’s stock after purchasing an additional 1,931 shares during the period. Sterling Capital Management LLC’s […] - 2025-04-24 05:46:54
Legal & General Group Plc Has $4.91 Million Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)
Legal & General Group Plc lessened its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 6.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 216,507 shares of the life sciences company’s stock after selling 16,109 shares during the quarter. Legal & […] - 2025-04-22 04:44:49
Sei Investments Co. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)
Sei Investments Co. trimmed its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 18,953 shares of the life sciences company’s stock after selling 4,448 shares during the period. Sei Investments Co.’s holdings in Integra LifeSciences were worth $430,000 at the […] - 2025-04-10 04:24:49
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Vanguard Group Inc.
Vanguard Group Inc. trimmed its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.1% in the fourth quarter, HoldingsChannel reports. The firm owned 7,580,967 shares of the life sciences company’s stock after selling 162,961 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Integra LifeSciences worth $171,936,000 at […] - 2025-04-07 04:41:00
Integra LifeSciences (NASDAQ:IART) Raised to Buy at Argus
Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Monday, MarketBeat Ratings reports. Separately, Morgan Stanley assumed coverage on shares of Integra LifeSciences in a research report on Monday, December 2nd. They issued an “underweight” rating […] - 2025-04-02 03:12:48
Quantbot Technologies LP Has $179,000 Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)
Quantbot Technologies LP lowered its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 89.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,881 shares of the life sciences company’s stock after selling 64,470 shares during the period. Quantbot Technologies LP’s holdings in Integra LifeSciences were worth $179,000 at the end of […] - 2025-03-31 04:39:00
Intech Investment Management LLC Acquires 11,174 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)
Intech Investment Management LLC raised its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 24,113 shares of the life sciences company’s stock after acquiring an additional 11,174 shares during the period. Intech Investment Management LLC’s holdings in Integra LifeSciences were worth […] - 2025-03-25 07:08:55
PNC Financial Services Group Inc. Grows Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)
PNC Financial Services Group Inc. lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,755 shares of the life sciences company’s stock after purchasing an additional […] - 2025-03-20 05:57:04
Integra LifeSciences Holdings Co. (NASDAQ:IART) Holdings Lowered by Bank of New York Mellon Corp
Bank of New York Mellon Corp cut its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 467,962 shares of the life sciences company’s stock after selling 15,830 shares […] - 2025-03-14 05:05:06
Amalgamated Bank Sells 478 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)
Amalgamated Bank reduced its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,394 shares of the life sciences company’s stock after selling 478 shares during the quarter. Amalgamated Bank’s holdings […] - 2025-03-05 08:26:53
Yousif Capital Management LLC Sells 906 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)
Yousif Capital Management LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.4% in the 4th quarter, HoldingsChannel reports. The firm owned 25,762 shares of the life sciences company’s stock after selling 906 shares during the quarter. Yousif Capital Management LLC’s holdings in Integra LifeSciences were worth $584,000 […] - 2025-02-17 06:42:58

iShares US Medical Devices UCITS ETF IART holdings

DateNumber of IART Shares HeldBase Market Value of IART SharesLocal Market Value of IART SharesChange in IART Shares HeldChange in IART Base ValueCurrent Price per IART Share HeldPrevious Price per IART Share Held
2025-09-30 (Tuesday)9,431USD 135,146USD 135,146
2025-09-29 (Monday)9,431USD 128,545IART holding increased by 4056USD 128,5450USD 4,056 USD 13.63 USD 13.2
2025-09-26 (Friday)9,431USD 124,489IART holding increased by 188USD 124,4890USD 188 USD 13.2 USD 13.18
2025-09-25 (Thursday)9,431IART holding increased by 584USD 124,301IART holding increased by 1239USD 124,301584USD 1,239 USD 13.18 USD 13.91
2025-09-24 (Wednesday)8,847USD 123,062IART holding decreased by -13005USD 123,0620USD -13,005 USD 13.91 USD 15.38
2025-09-18 (Thursday)8,847USD 136,067IART holding increased by 5131USD 136,0670USD 5,131 USD 15.38 USD 14.8
2025-09-17 (Wednesday)8,847USD 130,936IART holding decreased by -265USD 130,9360USD -265 USD 14.8 USD 14.83
2025-09-16 (Tuesday)8,847USD 131,201USD 131,201
2025-09-15 (Monday)8,847USD 133,324USD 133,324
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IART by Blackrock for IE00BMX0DF60

Show aggregate share trades of IART

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY584 13.180* 18.51
2025-06-27SELL-152 12.290* 19.57 Profit of 2,975 on sale
2025-06-12BUY225 12.690* 20.08
2025-06-10SELL-1,184 13.980* 20.18 Profit of 23,894 on sale
2025-06-09SELL-1,406 13.880* 20.23 Profit of 28,442 on sale
2025-05-30SELL-146 12.660* 20.58 Profit of 3,005 on sale
2025-05-19BUY73 13.550* 21.20
2025-05-09SELL-405 12.250* 21.64 Profit of 8,765 on sale
2025-04-23SELL-79 16.260* 22.42 Profit of 1,771 on sale
2025-04-17SELL-78 15.830* 22.71 Profit of 1,772 on sale
2025-04-10BUY608 17.420* 23.07
2025-04-04SELL-152 19.570* 23.26 Profit of 3,535 on sale
2025-04-02SELL-152 21.780* 23.27 Profit of 3,538 on sale
2025-03-31SELL-228 21.990* 23.31 Profit of 5,315 on sale
2025-03-19SELL-74 22.820* 23.42 Profit of 1,733 on sale
2025-02-28SELL-146 23.210* 23.58 Profit of 3,443 on sale
2025-02-05BUY228 26.550* 23.41
2025-02-04BUY304 26.050* 23.35
2025-01-29SELL-76 26.120* 23.05 Profit of 1,752 on sale
2025-01-23SELL-76 25.600* 22.71 Profit of 1,726 on sale
2025-01-02SELL-146 23.020* 22.70 Profit of 3,314 on sale
2024-12-04BUY219 24.110* 22.45
2024-12-03SELL-73 24.630* 22.37 Profit of 1,633 on sale
2024-12-02SELL-876 24.580* 22.28 Profit of 19,518 on sale
2024-11-29SELL-1,480 24.580* 22.19 Profit of 32,839 on sale
2024-11-27SELL-222 24.540* 21.98 Profit of 4,880 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IART

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19200,8600342,32458.7%
2025-09-18245,5230426,03657.6%
2025-09-17219,2980308,53571.1%
2025-09-16189,7360339,12355.9%
2025-09-15311,4050512,19560.8%
2025-09-12205,9090320,82364.2%
2025-09-11350,4390718,80048.8%
2025-09-10247,9430396,70862.5%
2025-09-09260,9410485,21053.8%
2025-09-08306,988528453,32567.7%
2025-09-05346,9370460,01475.4%
2025-09-04398,3590759,82652.4%
2025-09-03485,8670778,19662.4%
2025-09-02231,9760373,41462.1%
2025-08-29417,210981707,67059.0%
2025-08-28323,7330583,37855.5%
2025-08-27557,4988071,292,64743.1%
2025-08-26315,9440528,77859.7%
2025-08-25317,2050482,38965.8%
2025-08-22382,7240717,89153.3%
2025-08-21178,7370284,39462.8%
2025-08-20341,58231691,27249.4%
2025-08-19368,7190685,72853.8%
2025-08-18371,7150701,23253.0%
2025-08-15327,2060620,44552.7%
2025-08-14241,9660473,34951.1%
2025-08-13265,549526710,39937.4%
2025-08-12269,6440810,62333.3%
2025-08-11306,6000800,14738.3%
2025-08-08362,062300898,71540.3%
2025-08-07382,3000998,59838.3%
2025-08-06441,39253927,92147.6%
2025-08-05491,0340872,42956.3%
2025-08-04313,62166,725657,28247.7%
2025-08-01645,71940,049960,27167.2%
2025-07-31937,68601,264,83774.1%
2025-07-30268,4190456,37058.8%
2025-07-29234,7190447,92852.4%
2025-07-28285,5980597,58147.8%
2025-07-25215,394110504,27642.7%
2025-07-24244,6990492,63549.7%
2025-07-23221,7840517,97342.8%
2025-07-22184,579787359,37751.4%
2025-07-21203,1600367,50055.3%
2025-07-18187,7900327,24857.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.